Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$96,431
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-17 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +20,000 20,000
2019-03-26 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +38,000 38,000
2019-01-02 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +30,000 30,000
2018-05-21 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +50,016 50,016
2017-09-22 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +50,000 50,000
2017-06-06 Tasker Sybil Chief Medical Officer Grant or award · Stock Options (option to buy) +40,000 40,000
2017-05-04 Tasker Sybil Grant or award · Stock Options (option to buy) +48,691 48,691

Page 1 of 1 · 7 trades